Ekso Bionics Holdings, Inc. (EKSO) |
| 11.8 0.15 (1.29%) 05-15 16:00 |
| Open: | 11.4 |
| High: | 11.8 |
| Low: | 11.4 |
| Volume: | 95,135 |
| Market Cap: | 29(M) |
| PE Ratio: | -2.31 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 20.34 |
| Resistance 1: | 15.58 |
| Pivot price: | 12.38 |
| Support 1: | 7.89 |
| Support 2: | 6.56 |
| 52w High: | 13.5 |
| 52w Low: | 2.73 |
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
| EPS | -5.110 |
| Book Value | 2.540 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.921 |
| Profit Margin (%) | -91.37 |
| Operating Margin (%) | -119.71 |
| Return on Assets (ttm) | -33.6 |
| Return on Equity (ttm) | -107.6 |
Thu, 04 Jun 2026
ChronoScale (NASDAQ: CHRN) plans Ekso divestiture to become cloud-focused - Stock Titan
Mon, 18 May 2026
[Form 4] EKSO BIONICS HOLDINGS, INC. Insider Trading Activity - Stock Titan
Tue, 05 May 2026
Applied Digital Cloud Corporation completed the acquisition of Ekso Bionics Holdings, Inc. in a reverse merger transaction. - marketscreener.com
Fri, 20 Mar 2026
Ekso Bionics (EKSO) COO Jones buys $15,499 in company stock - Investing.com
Thu, 19 Feb 2026
Firm Advises Ekso Bionics on Contribution and Exchange Agreement with Applied Digital - Wilson Sonsini
Tue, 17 Feb 2026
Ekso Bionics to Combine With Applied Digital Cloud; Issuing 138.2M Shares, Rebrands ChronoScale - TradingView
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |